BD MAX MRSA assay gets European approval

27 November 2011 (Last Updated November 27th, 2011 18:30)

BD Diagnostics has received the CE mark for an assay to identify patients infected with MRSA.

BD Diagnostics has received the CE mark for an assay to identify patients infected with MRSA.

The BD MAX MRSA assay is the fully automated, bench-top molecular system designed to provide clinicians the flexibility to perform CE and in vitro diagnostic assays on the same platform.

The dual functionality of the BD MAX System allows laboratories to perform a range of molecular tests on a single workstation.